
Voy is redefining weight management at scale, combining cutting-edge digital innovation with evidence-based clinical care. As our Medical Director for Obesity and Metabolic Health, you will shape the clinical future of one of the UK's fastest-growing digital health services. You will define how evidence-based obesity care is delivered at scale, helping thousands of patients access safe, effective, and sustainable treatment through technology-enabled healthcare.
As the most senior clinical voice for this division, you will own both high-level strategy and day-to-day clinical integrity. This is not a passive, purely managerial role. We are looking for an intellectually curious, highly motivated leader who loves to execute. You don't need to be a lifelong specialist in obesity or metabolic health, but you must be a sharp, agile clinician who can rapidly master the clinical landscape, command a room, and hold your own with regulators, media, and internal teams alike.
You will act as a trusted clinical partner and right-hand to our CMO, stepping up to provide leadership continuity during their absence, while serving as the public face of Voy's metabolic division.
Lead the division: Act as the senior clinical leader for the Obesity & Metabolic Health division, accountable for the clinical quality, safety and performance of services delivered within the division.
Lead divisional clinical quality, safety and governance: Keep our clinical engine watertight. You'll maintain governance processes, pathways, and SOPs, leading audits, incident reviews, and ensuring DCB0129 compliance.
Partner with the Quality & Risk function: Collaborate closely with the Director of Quality & Risk to embed Voy's framework within your division, proactively managing risks, incidents, and audits while driving continuous organisational learning and regulatory compliance.
Partner with the CMO: Drive follow-through on CMO priorities at pace. You will draft high-quality briefing notes, decision papers, and step into the CMO role seamlessly during periods of absence.
Drive digital & product innovation: Partner cross-functionally with product, data, and coaching teams to design and optimise digital interventions, patient pathways, and behavioural support programs.
External affairs & thought leadership: Serve as Voy's primary external clinical spokesperson. You'll represent the business in the media, at industry conferences, and with regulators, shaping a responsible public narrative around metabolic health.
Personally execute: Roll up your sleeves. You will personally lead and deliver high-priority clinical projects rather than just overseeing them, moving from strategy to execution quickly.
Hybrid working: We believe that the future of healthcare is digital, but the future of our team relies on strong, in-person collaboration. Therefore, this is a hybrid position on a full-time basis, based out of our London office.
An Individually Contributing Leader: You move from strategy to execution with urgency and creativity, producing high-quality outputs without needing to be micro-managed.
Adaptable & Intellectually Curious: You have a strong medical background and the cognitive agility to quickly master obesity care, digital health trends, and emerging treatments (GLP-1/GIP therapies).
A Master Communicator: You possess the natural presence, authority, and charisma to represent Voy in high-stakes media, industry, and professional settings.
A Cross-Functional Collaborator: You easily influence and speak the language of product managers, data scientists, and commercial teams, balancing clinical safety with commercial feasibility.
An Experienced Clinician: You are a GMC-registered medical professional with experience owning clinical governance and safety in a complex healthcare environment. (Experience specific to metabolic health is a plus, but a driving, go-getter attitude is mandatory).
The metabolic and obesity division has clear clinical leadership and strong day-to-day clinical running.
BAU clinical governance is reliable, well-documented, and continuously improving.
Clinical risks are identified early, managed effectively, and escalated appropriately.
Product and service changes are clinically sound, evidence-based, and implemented safely.
The CMO has a trusted clinical partner who meaningfully increases medical leadership capacity and executes on important priorities.
There is genuine continuity of medical leadership when the CMO is away.
Voy has a credible, responsible, and influential external clinical voice in obesity and metabolic health.
Patient outcomes, safety, quality, and service performance improve over time.
The Medical Director is seen internally as a senior clinical leader who gets things done.